2 news items
Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights
RLAY
2 May 24
in the second half of 2024RLY-2608 + fulvestrant + ribociclib initial safety data in the second half of 2024 Lirafugratinib
Canada's Strategic Move Towards AI: An Investor and Trader's Perspective
AMZN
BTAI
CERT
9 Apr 24
Environment
A further noteworthy allocation is the $50 million for establishing an AI safety institute
- Prev
- 1
- Next